Clinical Trial Update: Intravitreal Injections-related Anxiety [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 studies evaluating anxiety related to intravitreal injections in age-related macular de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: University Health Network, Toronto | Conditions: Age-related Macular Degeneration | Phase 2, Phase 3 | Status: COMPLETED